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UNIT 4.18Synthesis of Oligonucleotide Conjugates via
Aqueous Diels-Alder Cycloaddition
This unit describes in detail the preparation of 5′-labeled oligonucleotides via the aqueous
Diels-Alder conjugation method. The unit is divided into three protocols: the first
describing the preparation of the diene-amidite (see Basic Protocol 1); the second
presenting the modification of oligonucleotides with the diene-amidite (see Basic Proto-
col 2); and the third describing the labeling of 5′-diene-modified oligonucleotides via
Diels-Alder conjugation with TAMRA-5-maleimide (see Basic Protocol 3). All proce-
dures are simple to perform with standard equipment and reagents.
CAUTION: All reactions must be performed in a well-ventilated fume hood. The use of
proper laboratory precautions when handling all chemicals is mandatory. In particular,
exposure of personnel to tert-butyldimethylsilyl chloride, bromine, 1,1′-carbonyldiimi-
dazole, 2-cyanoethyl diisopropylchlorophosphoramidite, and N,N-diisopropylethy-
lamine must be avoided.
BASIC
PROTOCOL 1
SYNTHESIS OF THE DIENE-AMIDITE
The five-step synthesis route for the diene-amidite (S.7) employs commercially available
3-cyclohexene-1-methanol (S.1) as the starting material (Fig. 4.18.1). In the first step, the
hydroxyl group of S.1 is protected by silylation with tert-butyldimethylsilyl chloride
(TBDMS⋅Cl) to give the alkene S.2. In the next step, bromine is added. The resulting
dibromide (S.3) is subjected to a bis-dehydrohalogenation reaction with potassium
tert-butoxide to form the diene S.4. Removal of the TBDMS protecting group with
strongly acidic Dowex resin and subsequent distillation of the crude product leads to pure
2,4-cyclohexadiene-1-methanol (S.5). Conjugation of S.5 to 6-amino-1-hexanol is ac-
complished in reaction with 1,1′-carbonyldiimidazole (CDI). The crude carbamate S.6 is
purified by crystallization. Finally, S.6 is converted into the phosphoramidite S.7 by
treatment with 2-cyanoethyl diisopropylchlorophosphoramidite and N,N-diiso-
propylethylamine (DIPEA). Purification of the crude product is performed by flash
chromatography.
Materials
3-Cyclohexene-1-methanol (S.1; Aldrich)
Imidazole
Argon source
N,N-Dimethylformamide (DMF)
tert-Butyldimethylsilyl chloride (TBDMS⋅Cl; Aldrich)
Hexanes
Ethyl acetate (EtOAc)
TLC stain (see recipe)
Brine (saturated aqueous NaCl)
Magnesium sulfate (MgSO4)
Bromine
Dichloromethane (CH2Cl2)
10% (w/v) sodium thiosulfate (Na2S2O3)
Aliquat 336 (tricaprylylmethylammonium chloride; Aldrich)
Tetrahydrofuran (THF)
Potassium tert-butoxide (Aldrich)
Saturated ammonium chloride (NH4Cl)
Dowex 50WX4-50 strongly acidic ion-exchange resin (Aldrich)
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Methanol
1,1′-Carbonyldiimidazole (CDI; Aldrich)
6-Amino-1-hexanol (Aldrich)
N,N-Diisopropylethylamine (DIPEA; Aldrich)
2-Cyanoethyl diisopropylchlorophosphoramidite (Aldrich)
Saturated sodium bicarbonate (NaHCO3)
100- and 250-mL round-bottom flasks with outlet stopcock adapters for gas line
TLC plates: 7.5 × 5–mm silica gel 60 F254 precoated aluminum-backed TLC sheets
(EM Science)
Heat gun
1-L and 500-mL separatory funnels
Rotary evaporator equipped with a vacuum pump and vacuum controller
Rubber septa
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Figure 4.18.1 Preparation of diene-amidite (S.7). Abbreviations: Aliquat 336, tricaprylylmethylam-
monium chloride; CDI, 1,1′-carbonyldiimidazole; DIPEA, N,N-diisopropylethylamine; TBDMS⋅Cl,
tert-butyldimethylsilyl chloride.
Supplement 14 Current Protocols in Nucleic Acid Chemistry
4.18.2
Synthesis of
Oligonucleotide
Conjugates via
Diels-Alder
Cycloaddition
10- and 50-mL vials
3- and 5-mL syringes with 2-in., 20-G stainless steel needles
Shaker
Short-path distillation apparatus (Aldrich)
Biotage Flash 40 chromatography system with Flash 40M silica cartridge
Additional reagents and equipment for TLC (APPENDIX 3D) and flash
chromatography (APPENDIX 3E)
Perform silylation
1. Weigh 2.78 g (24.8 mmol) of 3-cyclohexene-1-methanol (S.1) and 3.38 g (49.6 mmol)
of imidazole into a 100-mL round-bottom flask equipped with a magnetic stir bar
and an argon inlet. Apply an atmosphere of argon.
2. Add 25 mL of DMF and stir until all solids are dissolved.
3. Add 4.49 g (29.8 mmol) TBDMS⋅Cl to the reaction mixture and stir for 20 hr at room
temperature. Monitor reaction by TLC (APPENDIX 3D) using 100:1 (v/v) hexanes/ethyl
acetate. Visualize spots by treating plate with TLC stain and heating with a heat gun.
TLC (hexanes/EtOAc 100:1): Rf = 0.05 for starting material (S.1); 0.29 for TBDMS-ether
(S.2).
Perform aqueous workup of S.2
4. Pour the reaction mixture into a 1-L separatory funnel. Add 250 mL of brine and
extract the product with 150 mL of hexanes.
5. Repeat the extraction twice with 150 mL each of hexanes.
6. Combine the hexanes fractions and wash with 250 mL of brine.
7. After separation dry the organic phase over MgSO4.
8. Remove the MgSO4 by filtration and wash it twice, each time with 20 mL of hexanes.
9. Concentrate the combined filtrates under vacuum using a rotary evaporator equipped
with a vacuum pump.
Typical yield of 4-(tert-butyldimethylsilyloxymethyl)cyclohex-1-ene (S.2): 5.62 g (100%)
as colorless liquid. TLC (hexanes): Rf = 0.29; 13C NMR (CDCl3): δ 127.0, 126.2, 68.0,
36.3, 28.2, 26.0, 25.7, 25.3, 24.8, 18.4, –5.3.
Brominate alkene
10. Weigh 5.62 g (24.8 mmol) of S.2 into a 250-mL round-bottom flask equipped with
a magnetic stir bar.
11. Add 50 mL of CH2Cl2, seal the flask with a rubber septum, and apply an atmosphere
of argon. Dissolve the silyl ether (S.2) under stirring, then cool the solution with an
ice bath to 0°C.
12. In a separate 10-mL vial, dissolve 1.3 mL (25.2 mmol) of bromine in 3 mL of CH2Cl2.
Fill a 5-mL syringe with the bromine/CH2Cl2 solution.
13. Attach the syringe to the flask (step 11) using a 20-G stainless steel needle to pierce
the septum, and add the bromine solution dropwise under cooling.
At the beginning, the red color disappears immediately after addition. Finally, an orange-
red color remains.
14. After complete addition of the bromine solution, remove the ice bath and let the
mixture stir for another 60 min. Monitor by TLC (see step 3).
TLC (hexanes/EtOAc 100:1): Rf = 0.29 for TBDMS-ether (S.2); 0.15 for dibromide (S.3).
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Perform aqueous workup of S.3
15. Pour the reaction mixture into a 500-mL separatory funnel.
16. Rinse the flask with 150 mL of CH2Cl2 and add to the separatory funnel.
17. Wash the CH2Cl2 layer with 150 mL of 10% Na2S2O3, then with 150 mL of water.
18. Dry the organic phase over MgSO4.
19. Remove the MgSO4 by filtration and wash twice with 20 mL of CH2Cl2.
20. Concentrate the combined filtrates under vacuum in a rotary evaporator.
Typical yield of trans-1,2-dibromo-4-tert-butyldimethylsilyloxymethylcyclohexane (S.3):
9.19 g (96%) as yellow oil. TLC (hexanes/EtOAc 100:1): Rf = 0.15. 13C NMR (CDCl3): δ
67.3, 53.6, 53.5, 34.2, 31.41, 3.12, 3.88, 2.25, 2.3, –5.4.
Perform bis-dehydrohalogenation
21. Weigh 9.19 g (23.8 mmol) of S.3 and 0.20 g (0.5 mmol) of Aliquat 336 into a 250-mL
round-bottom flask equipped with a magnetic stir bar.
22. Add 70 mL of THF, seal the flask with an outlet stopcock adapter attached to an argon
line, and apply an atmosphere of argon. Dissolve the dibromide (S.3) under stirring,
then cool the solution with an ice bath to 0°C.
23. Open the reaction flask by removing the adapter, add 5.88 g (52.4 mmol) of potassium
tert-butoxide in one portion, seal the flask again with the adapter, and apply an
atmosphere of argon (a yellow precipitate is immediately formed). Remove the ice
bath after 5 min and continue stirring for 2 hr. Monitor by TLC.
TLC (hexanes/EtOAc 100:1): Rf = 0.15 for dibromide (S.3); 0.25 for diene (S.4).
Perform aqueous workup of S.4
24. Pour the reaction mixture into a 500-mL separatory funnel.
25. Rinse the flask with 100 mL of hexanes and add to the separatory funnel.
26. Wash the hexanes layer with 100 mL saturated NH4Cl.
27. After separation, extract the aqueous phase with 50 mL of hexanes and wash the
combined hexanes phases with 100 mL of water.
28. Dry the organic phase over MgSO4.
29. Remove the MgSO4 by filtration and wash it twice, each time with 20 mL of hexanes.
30. Concentrate the combined filtrates under vacuum at 40°C, with pressure ≥180 mbar,
in a rotary evaporator.
Perform desilylation
31. Weigh 8.60 g of Dowex 50WX4-50 into a 50-mL vial and wash it carefully three
times, each time with 20 mL methanol.
After the third washing, the supernatant should be colorless.
32. Dissolve the S.4 residue from step 30 in 80 mL methanol, transfer it into a 250-mL
round-bottom flask, and add the washed Dowex 50WX4-50 resin.
33. Attach the flask to a shaker and shake the reaction mixture for 2 hr at 200 rpm. Monitor
by TLC using 3:1 (v/v) hexanes/ethyl acetate.
TLC (hexanes/EtOAc 3:1): Rf = 0.80 for diene (S.4); 0.20 for diene-alcohol (S.5).
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Purify diene-alcohol S.5
34. Remove the ion-exchange resin by filtration and wash it twice with 20 mL methanol.
35. Concentrate the combined filtrates under vacuum at 40°C, with pressure ≥180 mbar,
in a rotary evaporator.
36. Transfer the residue into a round-bottom flask of appropriate size (5 or 10 mL) and
attach it to a short-path distillation apparatus. Distill the product under vacuum,
collecting the fraction ranging from b.p. 47°C (2.2 mbar) to 50°C (1.7 mbar).
Typical yield of 2,4-cyclohexadiene-1-methanol (S.5): 2.20 g (84%) as colorless liquid.
TLC (hexanes/EtOAc 3:1): Rf = 0.20. 1H NMR (CDCl3): δ 5.98 - 5.62 (m, 4 H), 3.58 (d, J
= 5.9 Hz, 2 H), 2.56 - 2.42 (m, 1 H), 2.37 - 2.05 (m, 2 H), 1.50 (s, 1 H). 13C NMR (CDCl3):
δ 126.9, 125.4, 125.0, 123.6, 64.6, 35.5, 24.9.
Conjugate diene-alcohol to 6-amino-1-hexanol
37. Weigh 2.20 g (20.0 mmol) of S.5 into a 100-mL round-bottom flask equipped with
a magnetic stir bar.
38. Add 20 mL of DMF, seal the flask with an outlet stopcock adapter attached to an
argon line, and apply an atmosphere of argon. Dissolve the diene (S.5) under stirring.
39. Open the reaction flask by removing the adapter, add 3.40 g (21.0 mmol) of CDI in
one portion, seal the flask again with the adapter, and apply an atmosphere of argon.
Continue stirring for 1 hr. Monitor by TLC using 1:1 (v/v) hexanes/ethyl acetate.
TLC (hexanes/EtOAc 1:1): Rf = 0.32 for alcohol (S.5); 0.20 for the imidazolyl carbamate.
40. Open the reaction flask by removing the adapter, add 2.34 g (20.0 mmol) of
6-amino-1-hexanol in one portion, seal the flask again with the adapter, and apply an
atmosphere of argon. Continue stirring overnight. Monitor by TLC using 1:2 (v/v)
hexanes/ethyl acetate.
TLC (hexanes/EtOAc 1:2): Rf = 0.56 for the imidazolyl carbamate; 0.44 for carbamate
(S.6).
Perform aqueous workup of carbamate S.6
41. Concentrate the reaction mixture under vacuum in a rotary evaporator.
42. Dissolve the residue in 100 mL of CH2Cl2 and transfer the solution into a 250-mL
separatory funnel.
43. Wash the CH2Cl2 layer twice, each time with 70 mL of water.
44. After separation, dry the organic phase over MgSO4.
45. Remove the MgSO4 by filtration and wash it twice, each time with 10 mL of CH2Cl2.
46. Concentrate the combined filtrates under vacuum in a rotary evaporator.
47. Recrystallize the crude product from CH2Cl2.
Typical yield of 6-(cyclohexa-1,3-dien-5-yl)methylcarbamoylhexan-1-ol (S.6): 2.53 g
(50%) as colorless crystals, m.p. 65°C. TLC (hexanes/EtOAc 1:2): Rf = 0.44. 1H NMR (300
MHz, CD3CN): δ 6.01-5.96 (m, 1H), 5.94-5.89 (m, 1H), 5.86-5.78 (m, 1H), 5.72-5.67 (m,
1H), 5.51 (bs, 1H), 3.96-3.89 (m, 2H), 3.49 (q, J = 5.6 Hz, 2H), 3.08 (q, J = 6.6 Hz, 2H),
2.68-2.50 (m, 1H), 2.49 (t, J = 5.6 Hz, 1H), 2.31-2.21 (m, 1H), 2.15-2.02 (m, 1H), 1.54-1.45
(m, 4H), 1.40-1.26 (m, 4H). 13C NMR (75 MHz, CD3 CN): δ 156.8, 127.0, 126.0, 125.6,
125.0, 61.7, 61.5, 40.7, 33.0, 32.8, 29.9, 26.5, 25.5, 25.0. MS (FAB): m/z 254 [M+H]+.
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Perform phosphitylation
48. Weigh 2.53 g (10.0 mmol) of S.6 into an oven-dried 100-mL round-bottom flask
equipped with a magnetic stir bar.
49. Add 25 mL of dry THF and 2.6 mL (15 mmol) of DIPEA, seal the flask with a septum,
and apply an atmosphere of argon. Dissolve the alcohol (S.6) under stirring.
50. Weigh 2.49 g (10.5 mmol) of 2-cyanoethyl diisopropylchlorophosphoramidite into a
3-mL syringe.
51. Attach the syringe to the flask via the septum and add the chlorophosphoramidite
dropwise. Rinse the syringe with 3 mL of dry THF and add this solution to the reaction
mixture. Continue stirring for 1 hr. Monitor by TLC using ethyl acetate.
TLC (EtOAc): Rf = 0.50 for carbamate (S.6); 0.83 for amidite (S.7).
Perform aqueous work-up and purification of S.7
52. Pour the reaction mixture into a 250-mL separatory funnel.
53. Add 75 mL of CH2Cl2 and wash the organic layer three times with 75 mL saturated
NaHCO3.
54. Dry the organic phase over MgSO4.
55. Remove the MgSO4 by filtration and wash it twice with 10 mL CH2Cl2.
56. Concentrate the combined filtrates under vacuum in a rotary evaporator.
57. Dissolve the residue in 4 mL ethyl acetate and inject it on a Biotage Flash 40
chromatography system employing a Biotage Flash 40M silica gel cartridge equili-
brated with ethyl acetate. Elute the product with ethyl acetate.
58. Concentrate the product-containing fractions under vacuum in a rotary evaporator.
Dry the residue under high vacuum.
Typical yield of 1-[(2-cyanoethoxy)diisopropylaminophosphinyloxy]-6-(cyclohexa-1,3-
dien-5-yl)methylcarbamoylhexane (S.7): 3.40 g (75%) as colorless oil. TLC (EtOAc): Rf
= 0.83. 1H NMR (CD3CN): δ 6.01-5.87 (m, 2H), 5.83-5.77 (m, 1H), 5.71 (m, 1H), 5.52 (bs,
1H), 3.97-3.89 (m, 2H), 3.89-3.70 (m, 2H), 3.70-3.56 (m, 4H), 3.07 (q, J = 6.6 Hz, 2H),
2.70-2.53 (m, 1 H), 2.66 (t, J = 5.9 Hz, 2H), 2.31-2.15 (m, 1H), 2.15-2.01 (m, 1H), 1.64-1.26
(m, 8H), 1.20 (s, 3H), 1.19, (s, 3H), 1.18 (s, 3H), 1.17 (s, 3H). 13C NMR (CD3 CN): δ 156.7,
127.0, 125.8, 125.3, 124.0, 118.9, 65.7, 63.6, 63.4, 58.6, 58.4, 43.1, 42.9, 40.7, 33.2, 31.2,
31.1, 29.9, 26.3, 25.6, 25.0, 24.2, 24.1, 20.4, 20.3. 31P NMR (CD3 CN): δ 148.0. MS (FAB):
m/z 455 [M+H]+. Anal. calcd. for C23H40N3O4P: C, 60.91; H, 8.89; N, 9.26; found: C,
60.55; H, 9.23; N, 9.10. RP-HPLC: Rt = 12.67 min; Waters Nova-Pak C18 column (4 m,
3.9 × 150 mm) eluting with a linear gradient from 40% to 100% A (solvent A, acetonitrile;
solvent B, 250 mM triethylammonium acetate, pH 6.5) in 15 min with a flow rate of 1
mL/min; UV detection performed at λ = 254 nm.
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BASIC
PROTOCOL 2
SYNTHESIS OF 5′-DIENE-MODIFIED OLIGONUCLEOTIDES
This protocol describes the setup and steps required for automated assembly of 5′-diene-
modified oligonucleotides on a 1-µmol scale. The protocol was developed for the
Expedite 8909 DNA synthesizer, but can easily be adapted to other automated DNA
synthesizers. The reactions carried out in each cycle are shown in Figure 4.18.2. For
further details on automated oligonucleotide synthesis, see APPENDIX 3C.
The instrument manufacturer’s synthesis protocol in DMTr-ON mode is applied for the
assembly of the oligonucleotide with standard reagents for solid-phase oligonucleotide
synthesis. The diene-amidite (S.7) is employed at a concentration of 50 mg/mL in
acetonitrile in the last coupling cycle. After completion of the synthesis, the oligonu-
cleotide is cleaved from the CPG support and subsequently deprotected by treatment with
concentrated ammonium hydroxide. Desalting of the crude oligonucleotide is accom-
plished by alcohol precipitation.
Materials
Dry acetonitrile (DNA synthesis grade; H2O content <30 µg/mL)
Deblock solution: trichloroacetic acid (TCA) in dichloromethane (Proligo)
Cap A solution: acetic anhydride in tetrahydrofuran (Proligo)
Cap B solution: 1-methylimidazole in tetrahydrofuran/pyridine (Proligo)
Oxidizer solution: iodine in tetrahydrofuran/water/pyridine (Proligo)
Activator: 0.25 M 4,5-dicyanoimidazole (DCI) in acetonitrile (Proligo)
50 mg/mL standard phosphoramidites [dT, dC(bz), dA(bz), and dG(ib); Proligo] in
dry acetonitrile
50 mg/mL diene-amidite (S.7; see Basic Protocol 1) in dry acetonitrile
Helium source
Concentrated ammonium hydroxide (NH4OH)
3 M sodium acetate (APPENDIX 2A)
Isopropanol
70% (v/v) ethanol
CPG N1
n−1 standard synthesis cycles
N-amidite
CPG N1.....Nn
standard synthesis cycle
diene-amidite 
CPG N1.....Nn P O
O
O
H
N
CN
O
O
cleavage/deprotection
conc. ammonia
3′ N1.....Nn P O
O
O−
H
N O
O
NH4
+
Figure 4.18.2 Synthesis of diene-modified oligonucleotides. Standard synthesis cycle: deblocking
(deblock solution); coupling (N-amidite/DCI); capping (Cap A and B solutions); oxidation (oxidizer
solution). N-amidite: standard dT, dC(bz), dA(bz), dG(ib) phosphoramidites.
Current Protocols in Nucleic Acid Chemistry Supplement 15
4.18.7
Synthesis of
Modified
Oligonucleotides
and Conjugates
Automated DNA synthesizer (e.g., Expedite 8909, PerSeptive Biosystems)
Synthesis column for 1-µmol scale (Proligo): controlled-pore glass (CPG; 500 Å
for <50-mers, 1000 Å for ≥50-mers)
Heating block
Speedvac evaporator
Additional reagents and equipment for quantitating oligonucleotides by OD260
measurement (UNIT 10.3)
Perform automated synthesis
1. Install the bottles with all reagents (acetonitrile, deblock solution, cap A and B
solutions, oxidizer solution, activator solution), phosphoramidite solutions [dT,
dC(bz), dA(bz), and dG(ib)], and diene-amidite S.7 in an automated DNA sythesizer
according to the manufacturer’s instructions (also see APPENDIX 3C). Flush with helium
and prime the fluidics system three times.
2. Use the sequence editor to enter a new sequence or edit an existing sequence for
synthesis.
3. Load the appropriate synthesis column for 1-µmol scale.
4. Choose the DMTr-ON option in the setup menu and perform the synthesis.
The standard synthesis cycle is applied in the last cycle for the diene-amidite (S.7) coupling.
Cycle steps are listed in Table 4.18.1.
5. Remove the synthesis column from the instrument.
6. Cleave the oligonucleotide from the solid support in the column by treatment with 1
mL concentrated ammonium hydroxide for 30 min at room temperature.
7. Collect the ammonia solution containing the oligonucleotide into a screw-cap tube
and deprotect the oligonucleotide by heating in a heating block at 55°C for 8 hr or
overnight.
8. Dry the deprotected oligonucleotide in a Speedvac evaporator.
Desalt oligonucleotides
9. Dissolve ∼100 OD260 units of crude oligonucleotide in 100 µL of deionized water.
10. Add 11 µL of 3 M sodium acetate solution and mix.
11. Add 333 µL of isopropanol, then vortex.
12. Incubate overnight at room temperature.
13. Microcentrifuge 10 min at maximum speed (≥10,000 × g), room temperature.
14. Remove the supernatant and discard; avoid disturbing the pellet.
15. Add 300 µL of 70% ethanol, mix briefly, and place in a freezer at −20°C for 2 hr.
16. Microcentrifuge 5 min at maximum speed (≥10,000 × g), room temperature.
17. Remove the supernatant and discard.
18. Evaporate pellet to dryness in a Speedvac evaporator.
19. Quantify the oligonucleotide by OD260 measurement (UNIT 10.3).
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Table 4.18.1 Standard Expedite 1-µmol DNA Synthesis Protocol Applied for Synthesis of
Diene-Modified Oligonucleotides using Diene-Amidite (S.7).
Operation Function Mode Amount Time (sec) Description
Deblocking
144 Index Fract.
Coll.
NA 1 0 Event out ON
0 Default WAIT 0 1.5 Wait
141 Trityl Mon.
On/Off
NA 1 1 START data
collection
16 Dblk PULSE 10 0 Dblk to column
16 Dblk PULSE 50 49 Deblock
38 Diverted Wsh
A
PULSE 40 0 Flush system with
Wsh A
141 Trityl Mon.
On/Off
NA 0 1 STOP data collection
38 Diverted Wsh
A
PULSE 40 0 Flush system with
Wsh A
144 Index Fract.
Coll.
NA 2 0 Event out OFF
Coupling
1 Wsh PULSE 5 0 Flush system with
Wsh
2 Act PULSE 5 0 Flush system with
Act
22 S.7 + Act PULSE 6 0 Monomer + Act to
column
22 S.7 + Act PULSE 1 8 Couple monomer
2 Act PULSE 4 32 Couple monomer
1 Wsh PULSE 7 56 Couple monomer
1 Wsh PULSE 8 0 Flush system with
Wsh
Capping
12 Wsh A PULSE 20 0 Flush system with
Wsh A
13 Caps PULSE 8 0 Caps to column
12 Wsh A PULSE 6 15 Cap
12 Wsh A PULSE 14 0 Flush system with
Wsh A
Oxidizing
15 Ox PULSE 15 0 Ox to column
12 Wsh A PULSE 15 0 Flush system with
Wsh A
Capping
13 Caps PULSE 7 0 Caps to column
12 Wsh A PULSE 30 0 End of cycle wash
aNA, not applicable.
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BASIC
PROTOCOL 3
LABELING OF A 5′-DIENE-MODIFIED OLIGONUCLEOTIDE WITH
TAMRA-5-MALEIMIDE
This protocol describes the conjugation of TAMRA-5-maleimide to a diene-modified
oligonucleotide via aqueous Diels-Alder cycloaddition (Fig. 4.18.3). The crude 5′-diene-
modified oligonucleotide is dissolved in sodium acetate buffer, pH 4.5, and treated with
a 10-fold excess of TAMRA-5-maleimide. The mixture is heated at 60°C for 4 hr. Excess
dye is removed by size-exclusion chromatography employing NAP-5 columns. The
labeled oligonucleotides obtained can be purified by high-performance liquid chroma-
tography (HPLC; UNIT 10.5) or polyacrylamide gel electrophoresis (PAGE; UNIT 10.4).
Materials
Diene-modified oligonucleotide (see Basic Protocol 2)
100 mM sodium acetate buffer, pH 4.5 (APPENDIX 2A)
40 mM TAMRA-5-maleimide solution: 5.0 mg TAMRA-5-maleimide (Molecular
Probes) in 268 µL dimethylformamide (DMF)
Heating block
NAP-5 columns (Amersham Pharmacia Biotech)
Speedvac evaporator
Additional reagents and equipment for quantitating oligonucleotides by OD260
measurement (UNIT 10.3)
Label diene-modified oligonucleotide
1. Prepare a 1 mM stock solution of the diene-modified oligonucleotide in deionized
water.
Calculations are based on the OD260 readings obtained (see Basic Protocol 2, step 19) and
the calculated extinction coefficient of the oligonucleotide (UNIT 10.3).
N
O
O
3′ N1.....Nn P O
O
O−
H
N O
O
N
O
O
3′ N1.....Nn P O
O
O−
H
N O
O
+
NaOAc buffer
pH 4.5 4 hr, 60 °C
TAMRA
TAMRA
Figure 4.18.3 Labeling of diene-modified oligonucleotide with TAMRA-5-maleimide via aqueous
Diels-Alder cycloaddition.
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2. In a 1.5-mL microcentrifuge tube, prepare a mixture of:
20 µL 1 mM diene-modified oligonucleotide (20 nmol)
50 µL 100 mM sodium acetate buffer, pH 4.5
25 µL deionized water
  5 µL 40 mM TAMRA-5-maleimide solution.
3. Incubate the mixture for 4 hr at 60°C in a heating block. If desired, store mixture up
to 2 to 4 weeks at −20°C.
Remove excess dye by size-exclusion chromatography
4. Remove the top of the NAP-5 column and discard the preservative solution into a
waste container. Remove the bottom cap.
5. Equilibrate the NAP-5 column with 10 mL of deionized water.
6. Load 100 µL of the labeling solution and allow it to enter the NAP-5 gel bed
completely.
7. Load 400 µL of deionized water; discard the eluate.
8. Elute twice, each time with 500 µL of deionized water, and collect 500-µL fractions
in separate vials.
9. Identify product-containing fractions by OD260 measurement (UNIT 10.3).
10. Combine the product-containing fractions and evaporate to dryness in a Speedvac
evaporator.
11. Optional: Purify crude oligonucleotide by RP-HPLC (UNIT 10.5) or PAGE (UNIT 10.4).
REAGENTS AND SOLUTIONS
Use deionized, distilled water in all recipes and protocol steps. For common stock solutions, see
APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
TLC stain
Solution A: Weigh 0.2 g of 3-methoxyphenol (Aldrich) into a 250-mL beaker and
add absolute ethanol to make 100 g of solution (0.2% w/w final).
Solution B: Add 5.3 mL concentrated sulfuric acid (H2SO4) to a 250-mL beaker
containing ∼50 mL of absolute ethanol. Add ethanol to make 100 mL (1 M H2SO4
final).
TLC stain: In a 250-mL screw-cap vial, mix equal volumes of solutions A and B
(usually 50 mL). Prepare fresh.
CAUTION: Sulfuric acid is corrosive. Avoid skin and eye contact. Addition of the acid to
ethanol is exothermic.
COMMENTARY
Background Information
The chemical synthesis of modified oli-
gonucleotides is of increasing interest for
studying biological processes in vivo and in
vitro, in particular for diagnostic applications.
Oligonucleotides are modified to prepare con-
jugates with reporter groups such as fluoropho-
res or biotin, ligands for radioactive labeling,
peptides, enzymes, antibodies, and carbohy-
drates (Goodchild, 1990). Other applications
require the attachment of oligonucleotides to
surfaces, e.g., to produce microarrays (Bowtell
and Sambrook, 2002) or to conjugate oligonu-
cleotides to nanoparticles (Letsinger et al.,
2000). A number of strategies have been ap-
plied to chemically modify oligonucleotides at
the 3′ and/or 5′ terminus (UNITS 4.2, 4.3, 4.5, & 4.6)
or in the middle of the sequence. For 3′-modi-
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fication, a branched linker is attached to the
solid support employed for oligonucleotide
synthesis. The linker either comprises a func-
tional group for postsynthetic modification re-
actions or an attached reporter group or ligand
that alleviates the need for postsynthetic modi-
fications (UNITS 4.5 & 4.6). Functionalized nucleo-
side building blocks are used to incorporate a
modification in the middle of the sequence
(Telser et al., 1989) or at the 5′ terminus (Smith
et al., 1985). For 5′-modification, a non-nu-
cleosidic phosphoramidite such as fluoro-
chrome amidite or a biotin-functionalized
amidite can be coupled to the oligonucleotide
in the last synthesis cycle (UNITS 4.2 & 4.3). Many
fluorochrome-phosphoramidites and other
amidites containing reporter groups of haptens
are commercially available to allow on-support
labeling.
As an alternative method, the phos-
phoramidite employed in the last synthesis cy-
cle can contain a protected functional group.
After its deprotection, the functional group is
available for postsynthetic conjugation to a
modifier containing the corresponding func-
tionality for attachment (UNIT 4.2). Examples of
standard conjugation methods are given in Fig-
ure 4.18.4. The Diels-Alder conjugation
method (Hill et al., 2001) extends the portfolio
of conjugation chemistries, as it contains some
unique features.
(1) The method is applicable for conjugation
reactions in aqueous media and therefore al-
lows postsynthetic labeling of oligonu-
cleotides.
(2) Protection of the functional group is not
necessary, as the diene moiety is stable under
the standard synthesis and deprotection condi-
tions employed for solid-phase oligonucleotide
synthesis.
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Figure 4.18.4 Common oligonucleotide conjugation methods. Abbreviations: FG, functional
group; MMTr, 4-monomethoxytrityl; TFA, 2,2,2-trifluoroacetyl.
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(3) The Diels-Alder conjugation reaction is fast
and selective for dienophiles, such as male-
imides.
(4) The method is orthogonal to other common
methods (see Fig. 4.18.4) and therefore allows
combination with other functionalities (e.g.,
amines) to prepare dual-labeled probes in one
pot.
Basic Protocol 3 allows for the conjugation
of diene-modified oligonucleotides to any sub-
strate containing maleimides or other suitable
dienophiles and allows the preparation of modi-
fied oligonucleotides used in the spectrum of
biological applications.
Critical Parameters
Synthesis of diene-alcohol
The synthesis of the diene-alcohol S.5 is
straightforward and can be conveniently per-
formed on a larger scale. It is not necessary to
purify intermediates S.2 to S.4, as compound
S.5 can be satisfactorily purified by fractional
distillation. For successful performance of the
bis-dehydrohalogenation, it is crucial to use
fresh potassium tert-butoxide and to use anhy-
drous conditions; otherwise, prolonged reac-
tion times or incomplete conversion will be
observed. If the reaction is not complete after
the time given in the protocol, an additional
portion of potassium tert-butoxide (∼10% of
the initial amount) should be added and the
reaction mixture stirred for another hour. Com-
pounds S.4 and S.5 appear to be volatile liquids.
After evaporation of the organic phases con-
taining these volatile intermediates, drying un-
der high vacuum should be avoided.
Purification and storage of diene-amidite
If wet silica gel is used for the flash chroma-
tography of diene-amidite S.7, the formation of
byproducts may be observed. Equilibration of
the column employing a 1% solution of
triethylamine in EtOAc, instead of EtOAc
alone, helps to buffer the acidic silica gel. Sub-
sequently, the column should be treated with
EtOAc to replace the triethylamine solution.
After purification, the amidite (S.7) should be
dried under high vacuum and stored under dry
argon in a refrigerator at 4°C. It is advantageous
to distribute the amidite to appropriate clean,
dry synthesizer bottles immediately after
preparation in order to avoid repeated opening
of the amidite container. The bottles should be
flushed with argon and sealed.
Oligonucleotide synthesis
The synthesizer used for oligonucleotide
synthesis should be operated and maintained
according to the manufacturer’s instructions. It
is crucial to use appropriate solvents and re-
agents and to prime all the lines carefully prior
to synthesis. A freshly prepared solution of
diene-amidite (S.7) should be used. It is not
necessary to prolong the coupling time for the
final diene-amidite coupling compared to cou-
pling of standard amidites.
Diels-Alder cycloaddition reaction
The reaction conditions for the Diels-Alder
conjugation reaction have given the best label-
ing results. For sensitive substrates, it could be
desirable to carry out the Diels-Alder conjuga-
tion under different reaction conditions, such
as lower temperature or higher pH. Successful
conjugation may only be possible in exchange
for a lower yield. Limitations are: (1) fast hy-
drolysis of maleimides at pH >8, (2) decreased
reaction rates at temperatures <35°C, and (3)
the requirement that DMF content not exceed
20%. Purification of crude oligonucleotide
conjugates can be performed by standard meth-
ods such as reversed-phase high-performance
liquid chromatography (RP-HPLC; UNIT 10.5) or
polyacrylamide gel elctrophoresis (PAGE; UNIT
10.4).
Anticipated Results
By applying the methods in this unit and
observing the critical parameters, it is possible
to prepare the diene-amidite (S.7) at a 30%
overall yield, with a purity of ≥98%, deter-
mined by RP-HPLC and 31P NMR analysis (see
Basic Protocol 2). Diene-functionalization of
oligonucleotides employing pure phos-
phoramidite (S.7) usually provides coupling
efficiencies >99%. The conjugation of diene-
functionalized oligonucleotides to maleimides
typically proceeds with efficiencies >80%.
Time Considerations
The preparation of diene-amidite (S.7) takes
∼2 weeks, if the scale given in the protocol is
applied. The time for the assembly of a 5′-diene-
modified oligonucleotide (synthesis of a 20-
mer on 1-µmol scale), including deprotection
and desalting, takes ~3 days. The conjugation
reaction, including size-exclusion chromatog-
raphy, typically requires 2 days.
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